Compared to placebo, low certainty evidence show that L-carnitine supplementation significantly changes (reduced) more in AST levels and ALT levels (MD: 26.38, 95%CI: 45.46 to 7.30), and moderate certainty evidence show that L-carnitine supplementation significantly changes (reduced) more in HDL cholesterol levels (MD: 1.14, 95%CI: 0.21 to 2.07) and triglyceride levels (MD: 6.92, 95%CI: 13.82 to 0.03)
N., Ma, R., Pickles, T., Rootman, J
Systemic subcutaneous injections are highly effective and much safer, avoiding the complex network of nerves and vessels within the muscle
The role of oxidative stress in hypertension: the insight into antihypertensive properties of vitamins A, C, and E